TIAA CREF INVESTMENT MANAGEMENT LLC

Holdings History for HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

Symbol: HALO on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019	0.01%	-0%	$8,481,000	526,796	-2,222	-0.42%	$16.10	Q1 2019
31 Dec 2018	0.01%	-0%	$7,740,000	529,018	-9,662	-1.8%	$14.63	Q4 2018
30 Sep 2018	0.01%	+0%	$9,788,000	538,680	+13,651	+2.6%	$18.17	Q3 2018
30 Jun 2018	0.01%	+0%	$8,857,000	525,029	+50,324	+11%	$16.87	Q2 2018
31 Mar 2018	0.01%	+0%	$9,299,000	474,705	+186,860	+65%	$19.59	Q1 2018
31 Dec 2017	0%	-0%	$5,832,000	287,845	-27,317	-8.7%	$20.26	Q4 2017
30 Sep 2017	0%	+0%	$5,474,000	315,162	+19,592	+6.6%	$17.37	Q3 2017
30 Jun 2017	0%	0%	$3,789,000	295,570	-43	-0.01%	$12.82	Q2 2017
31 Mar 2017	0%	-0%	$3,831,000	295,613	-14,208	-4.6%	$12.96	Q1 2017
31 Dec 2016	0%	-0%	$3,061,000	309,821	-16,144	-5%	$9.88	Q4 2016
30 Sep 2016	0%	-0%	$3,938,000	325,965	-16,071	-4.7%	$12.08	Q3 2016
30 Jun 2016	0%	-0%	$2,952,000	342,036	-20,414	-5.6%	$8.63	Q2 2016
31 Mar 2016	0%	-0%	$3,432,000	362,450	-58,936	-14%	$9.47	Q1 2016
31 Dec 2015	0.01%	-0%	$7,303,000	421,386	-20,336	-4.6%	$17.33	Q4 2015
30 Sep 2015	0%	-0%	$5,932,000	441,722	-20,613	-4.5%	$13.43	Q3 2015
30 Jun 2015	0.01%	-0%	$10,440,000	462,335	-8,160	-1.7%	$22.58	Q2 2015
31 Mar 2015	0%	-0%	$6,719,000	470,495	-17,688	-3.6%	$14.28	Q1 2015
31 Dec 2014	0%	-0%	$4,711,000	488,183	-24,363	-4.8%	$9.65	Q4 2014
30 Sep 2014	0%	-0%	$4,664,000	512,546	-64,675	-11%	$9.10	Q3 2014
30 Jun 2014	0%	+0%	$5,703,000	577,221	+221,090	+62%	$9.88	Q2 2014
31 Mar 2014	0%	-0%	$4,523,000	356,131	-2,810	-0.78%	$12.70	Q1 2014
31 Dec 2013	0%	0%	$5,381,000	358,941	0		$14.99	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.